Five-membered ring-fused six-membered ring compound, preparation method therefor, and pharmaceutical composition and use thereof
US12343343B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2024 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Apr 30, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed in the present invention are a five-membered ring-fused six-membered ring compound, a preparation method therefor, and a pharmaceutical composition and the use thereof. Provided in the present invention is a compound as represented by formula (I), or a pharmaceutically acceptable salt or an isotope compound thereof. The compound of the present invention has an inhibition and/or degradation effect on IRAK4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.